Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$6.7MFederal grants as PI3 awards
0Patents grantedNone matched
1,270Papers54,932 citations
Federal awards and patents by year
AwardsPatents
3 awards · $6.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2020 | NIH | SBIR Phase II Commercialization Readiness Pilot (CRP) to maximize vamorolone international labeling and sales | $3.4M | REVERAGEN BIOPHARMA, INC. |
| Sep 1, 2018 | NIH | SBIR Phase II Pivotal trial of vamorolone in Duchenne muscular dystrophy | $3.1M | REVERAGEN BIOPHARMA, INC. |
| Jun 5, 2018 | NIH | SBIR Phase I Definition of pharmacodynamic biomarkers for juvenile dermatomyositis for clinical trials | $225K | REVERAGEN BIOPHARMA, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#153
Awards as PI#822
Patents#273
Companies
- REVERAGEN BIOPHARMA, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.